18
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Helicobacter pylori (HP) is a facultative anaerobic bacterium. HP is a normal flora having immuno-modulating properties. This bacterium is an example of a microorganism inducing gastric cancer. Its carcinogenicity depends on bacteria-host related factors. The proper understanding of the biology of HP inducing gastric cancer offers the potential strategy in the managing of HP rather than eradicating it. In this article, we try to summarize the biology of HP-induced gastric cancer and discuss the current pharmacological approach to treat and prevent its carcinogenicity.

          Related collections

          Most cited references182

          • Record: found
          • Abstract: not found
          • Article: not found

          On the origin of cancer cells.

          O WARBURG (1956)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Inflammation and cancer: how hot is the link?

            Although inflammation has long been known as a localized protective reaction of tissue to irritation, injury, or infection, characterized by pain, redness, swelling, and sometimes loss of function, there has been a new realization about its role in a wide variety of diseases, including cancer. While acute inflammation is a part of the defense response, chronic inflammation can lead to cancer, diabetes, cardiovascular, pulmonary, and neurological diseases. Several pro-inflammatory gene products have been identified that mediate a critical role in suppression of apoptosis, proliferation, angiogenesis, invasion, and metastasis. Among these gene products are TNF and members of its superfamily, IL-1alpha, IL-1beta, IL-6, IL-8, IL-18, chemokines, MMP-9, VEGF, COX-2, and 5-LOX. The expression of all these genes are mainly regulated by the transcription factor NF-kappaB, which is constitutively active in most tumors and is induced by carcinogens (such as cigarette smoke), tumor promoters, carcinogenic viral proteins (HIV-tat, HIV-nef, HIV-vpr, KHSV, EBV-LMP1, HTLV1-tax, HPV, HCV, and HBV), chemotherapeutic agents, and gamma-irradiation. These observations imply that anti-inflammatory agents that suppress NF-kappaB or NF-kappaB-regulated products should have a potential in both the prevention and treatment of cancer. The current review describes in detail the critical link between inflammation and cancer.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

              Biopsy specimens were taken from intact areas of antral mucosa in 100 consecutive consenting patients presenting for gastroscopy. Spiral or curved bacilli were demonstrated in specimens from 58 patients. Bacilli cultured from 11 of these biopsies were gram-negative, flagellate, and microaerophilic and appeared to be a new species related to the genus Campylobacter. The bacteria were present in almost all patients with active chronic gastritis, duodenal ulcer, or gastric ulcer and thus may be an important factor in the aetiology of these diseases.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Oncol
                Front Oncol
                Front. Oncol.
                Frontiers in Oncology
                Frontiers Media S.A.
                2234-943X
                22 February 2019
                2019
                : 9
                : 75
                Affiliations
                [1] 1Alfarouk Biomedical Research LLC , Tampa, FL, United States
                [2] 2Hala Alfarouk Cancer Center , Khartoum, Sudan
                [3] 3Al-Ghad International College for Applied Medical Sciences , Medina, Saudi Arabia
                [4] 4American Biosciences, Inc. , New York City, NY, United States
                [5] 5Institute of Endemic Diseases, University of Khartoum , Khartoum, Sudan
                [6] 6College of Pharmacy, Qassim University , Buraydah, Saudi Arabia
                [7] 7Al-Ghad International College for Applied Medical Sciences , Jeddah, Saudi Arabia
                [8] 8College of Dentistry, Taibah University , Medina, Saudi Arabia
                [9] 9Department of Pharmacognosy, Faculty of Pharmacy, University of Khartoum , Khartoum, Sudan
                [10] 10Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Taibah University , Medina, Saudi Arabia
                [11] 11Al-Azhar University , Cairo, Egypt
                [12] 12Unaizah College of Pharmacy, Qassim University , Unaizah, Saudi Arabia
                [13] 13Clinical Pharmacy Department, College of pharmacy, Jazan University , Jazan, Saudi Arabia
                [14] 14Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University , Riyadh, Saudi Arabia
                [15] 15Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University , Richmond, VA, United States
                [16] 16University of Florence , Florence, Italy
                [17] 17School of Veterinary Medicine and Science, University of Nottingham , Nottingham, United Kingdom
                [18] 18Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari , Bari, Italy
                [19] 19Department of Oncology and Molecular Medicine, National Institute of Health , Rome, Italy
                [20] 20Institute for Clinical Biology and Metabolism , Vitoria, Spain
                Author notes

                Edited by: Tiziana Venesio, Institute for Cancer Research and Treatment (IRCC), Italy

                Reviewed by: Amit Gupta, All India Institute of Medical Sciences, Rishikesh, India; Cristiana Laudi, Istituto di Candiolo (IRCCS), Italy

                This article was submitted to Gastrointestinal Cancers, a section of the journal Frontiers in Oncology

                Article
                10.3389/fonc.2019.00075
                6395443
                30854333
                c118aed0-bc88-413a-8158-2ec4ecac1507
                Copyright © 2019 Alfarouk, Bashir, Aljarbou, Ramadan, Muddathir, AlHoufie, Hifny, Elhassan, Ibrahim, Alqahtani, AlSharari, Supuran, Rauch, Cardone, Reshkin, Fais and Harguindey.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 03 September 2018
                : 28 January 2019
                Page count
                Figures: 1, Tables: 1, Equations: 0, References: 211, Pages: 12, Words: 11685
                Categories
                Oncology
                Review

                Oncology & Radiotherapy
                helicobacter pylori,gastric cancer,ph,inflammation,pharmacology
                Oncology & Radiotherapy
                helicobacter pylori, gastric cancer, ph, inflammation, pharmacology

                Comments

                Comment on this article